Transglutaminase

转谷氨酰胺酶是 Ca2+ 依赖性酶,可通过脱酰胺、转酰胺或酯化来催化蛋白质的翻译后修饰,将蛋白质结合的 L-谷氨酰胺的 γ-羧酰胺基团转移到一级胺上。转谷氨酰胺酶超家族包括 TGM1-7 和因子 XIIIA,其中转谷氨酰胺酶 2 (TG2) 也称为组织转谷氨酰胺酶 (tTG),是最丰富且研究最广泛的成员。TG2 在组织中发挥多种作用,在肝脏和细胞质中高度表达,而其他同工型则表现出组织特异性表达:上皮组织中的 TG1、TG3 和 TG5;前列腺中的 TG4;血液中的因子 XIII (FXIII);脑、肺和睾丸中的 TG6;以及主要在睾丸和肺中的 TG7。 TG2 与多种人类疾病有关,包括先兆子痫、高血压、心血管疾病、器官纤维化、癌症、神经退行性疾病(如阿尔茨海默病)和乳糜泻(在这些疾病中,TG2 是一种关键的自身抗原)。该酶家族的功能多样性和病理相关性使其成为治疗研究的关键焦点[1][2]。

Transglutaminases are Ca²⁺-dependent enzymes that catalyze post-translational modifications of proteins by deamidation, transamidation, or esterification, transferring the γ-carboxamide group of protein-bound L-glutamine to primary amines. The transglutaminase superfamily includes TGM1-7 and Factor XIIIA, with Transglutaminase 2 (TG2), also known as tissue transglutaminase (tTG), being the most abundant and extensively studied member. TG2 plays diverse roles across tissues and is highly expressed in the liver and cytosol, while other isoforms exhibit tissue-specific expression: TG1, TG3, and TG5 in epithelial tissues; TG4 in the prostate gland; Factor XIII (FXIII) in blood; TG6 in the brain, lungs, and testis; and TG7 predominantly in the testis and lungs. TG2 has been implicated in a wide range of human diseases, including preeclampsia, hypertension, cardiovascular disease, organ fibrosis, cancer, neurodegenerative disorders such as Alzheimer's disease, and celiac disease, where it acts as a key autoantigen. This enzyme family’s functional diversity and pathological relevance make it a critical focus for therapeutic research[1][2].

Transglutaminase亚型特异性产品:Transglutaminase Isoform Comparison
共 4种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
MT-4

MT-4 是一种组织转谷氨酰胺酶 (TG2) 抑制剂的衍生物,可靶向 TG2 与纤连蛋白 (FN) 的复合体 (TG2/FN) 并抑制肿瘤细胞与基质的粘附,还能抑制卵巢癌 (OC) 细胞与腹膜的黏附,并增加卵巢癌细胞对紫杉醇的敏感性。

2327925-35-7
Inhibitor
99.84%
MT-4
PROTAC TG2 Degrader-3

PROTAC TG2 Degrader-3 是一种 TG2 (TGM2) PROTAC 降解剂,可抑制卵巢癌细胞的黏附和迁移,并可用于卵巢癌的研究(粉色:TGM2 配体 (MS-P02154);蓝色:VHL 配体 (MS-F94920);黑色:连接子 (MS-S10954))。

3054388-18-7
Inhibitor
PROTAC TG2 Degrader-3
Suvigletistat

Suvigletistat 是一种谷氨酰胺转移酶 2 (TG2) 抑制剂,其 IC50 <0.5 μM,可用于炎症性疾病的研究。

2410912-75-1
Inhibitor
99.82%
Suvigletistat
WRR139

WRR139 是一种参与炎症和癌症等疾病过程的肽乙烯基砜,同时也是胞质酶 N-聚糖酶 1 (NGLY1) 和 Nrf1 的抑制剂,并能增强 Carfilzomib 对癌细胞的细胞毒性。

2138924-36-2
Inhibitor
99.71%
WRR139

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础